Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.
Shedlock
Devon J
DJ
Biodefense Research Section, Vaccine Research Center, National Institute for Allergy and Infectious Disease, National Institutes of Health, 40 Convent Drive, MSC 3005, Bethesda, MD 20814, USA. shedlock@mail.med.upenn.edu
Bailey
Michael A
MA
Popernack
Paul M
PM
Cunningham
James M
JM
Burton
Dennis R
DR
Sullivan
Nancy J
NJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D057134:Antibodies, Neutralizing / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D029043:Ebolavirus / Q000276:immunology*; D000939:Epitopes / Q000276:immunology; D000882:Haplorhini; D006801:Humans; D009500:Neutralization Tests; D011485:Protein Binding; D014759:Viral Envelope Proteins / Q000276:immunology
D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D000939:Epitopes; D014759:Viral Envelope Proteins; C113189:envelope glycoprotein, Ebola virus